Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration

Toxicology

Volumn 315, Issue 1, 2014, Pages 1-7

  Bondy, Stephen C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aluminum toxicity; Brain senescence; Neuroinflammation; Neurological disease; Oxidative stress

Indexed keywords

ALUMINUM; ALUMINUM CONTAINING VACCINE; ALUMINUM SULFATE; AMYLOID BETA PROTEIN; DEFEROXAMINE; UNCLASSIFIED DRUG; VACCINE;

AGING; ALUMINUM OVERLOAD; ALUMINUM RELATED BONE DISEASE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; BONE DISEASE; BRAIN DISEASE; CEREBROSPINAL FLUID; CHELATION THERAPY; CHRONIC KIDNEY FAILURE; DEGENERATIVE DISEASE; DIALYSIS ENCEPHALOPATHY; DISEASE ASSOCIATION; DRUG FATALITY; ENVIRONMENTAL EXPOSURE; ERYTHEMA; HEMODIALYSIS; HUMAN; LONG TERM EXPOSURE; MYALGIA; NAUSEA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENESCENCE; SILICOSIS; VISUAL FIELD DEFECT;

EID: 84888801106     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.10.008     Document Type: Review

References (105)

1. Akatsu H., Hori A., Yamamoto T., Yoshida M., Mimuro M., Hashizume Y., Tooyama I., Yezdimer E.M. Transition metal abnormalities in progressive dementias. Biometals 2012, 25:337-350.
2. Akiyama H., Hosokawa M., Kametani F., Kondo H., Chiba M., Fukushima M., Tabira T. Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice. Neuropathology 2012, 32:390-397.
3. Altmann P., Al-Salihi F., Butter K., Cutler P., Blair J., Leeming R., Cunningham J., Marsh F. Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis. N. Engl. J. Med. 1987, 317:80-84.
4. Altmann P., Cunningham J., Dhanesha U., Ballard M., Thompson J., Marsh F. Disturbance of cerebral function in people exposed to drinking water contaminated with aluminum sulphate: retrospective study of the Camelford water incident. Br. Med. J. 1999, 319:807-811.
5. Altschuler E. Aluminum-containing antacids as a cause of idiopathic Parkinson's disease. Med. Hypotheses 1999, 53:22-23.
6. Alvarez-Soria M.J., Hernandez-Gonzalez A., Carrasco-Garcia de Leon S., Del Real-Francia M.A., Gallardo-Alcaniz M.J., Lopez-Gomez J.L. Demyelinating disease and vaccination of the human papillomavirus. Rev. Neurol. 2011, 52:472-476.
7. Andrasi E., Pali N., Molnar Z., Kosel S. Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J. Alzheimer's Dis. 2005, 7:273-284.
8. Authier F.J., Cherin P., Creange A., Bonnotte B., Ferrer X., Abdelmoumni D., Ranoux D., Pelletier J., Figarella-Branger D., Granel B., Maisonobe T., Coquet M., Degos J.D., Gherardi R.K. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001, 124:974-983.
9. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 2005, 25:8000-8009.
10. Bjertness E., Candy J.M., Torvik A., Ince P., McArthur F., Taylor G.A., Johansen S.W., Alexander J., Grønnesby J.K., Bakketeig L.S., Edwardson J.A. Content of brain aluminum is not elevated in Alzheimer's disease. Alzheimer's Dis. Assoc. Disord. 1996, 10:171-174.
11. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
12. Bolognin S., Messori L., Drago D., Gabbiani C., Cendron L., Zatta P. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity. Int. J. Biochem. Cell Biol. 2011, 43:877-885.
13. Bondy S.C., Guo-Ross S.X., Pien J. Mechanisms underlying the aluminum-induced potentiation of the pro-oxidant properties of transition metals. Neurotoxicology 1998, 19:65-71.
14. Bondy S.C. Aluminum. Encyclopedia of Neuroscience 2009, vol. 1:253-257. Academic Press, Oxford.
15. Bondy S.C. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 2010, 31:575-581.
16. Bondy S.C., Sharman E.H. Melatonin, oxidative stress and the aging brain. Oxidative Stress in Basic Research and Clinical Practice: Aging and Age-Related Disorders 2010, 339-357. Humana Press, Totowa, NJ. S.C. Bondy, K. Maiese (Eds.).
17. Bondy S.C., Truong A. Potentiation of beta-folding of β-amyloid peptide 25-35 by aluminum salts. Neurosci. Lett. 1999, 267:25-35.
18. Bouras C., Giannakopoulos P., Good P.F., Hsu A., Hof P.R., Perl D.P. A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. Eur. Neurol. 1997, 38:53-58.
19. Bowdler N.C., Beasley D.S., Fritze E.C., Goulette A.M., Hatton J.D., Hessian J., Ostman D.L., Rugg D.J., Schmittman C.J. Behavioural effects of aluminum ingestion on animal and human subjects. Pharmacol. Biochem. Behav. 1979, 10:505-512.
20. Burke W.J., Kumar V.B., Pandey N., Panneton W.M., Gan Q., Franko M.W., O'Dell M., Li S.W., Pan Y., Chung H.D., Galvin J.E. Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Acta Neuropathol. 2008, 115:193-203.
21. Burrell S.A., Exley C. There is (still) too much aluminium in infant formulas. BMC Pediatr. 2010, 10:63. 10.1186/1471-2431-10-63.
22. Campbell A., Becaria A., Lahiri D.K., Sharman K., Bondy S.C. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J. Neurosci. Res. 2004, 75:565-672.
23. Campbell A., Yang Y., Tsai-Turton M., Bondy S.C. Pro-inflammatory effects of aluminum in human glioblastoma cells. Brain Res. 2002, 933:62-65.
24. Chang J., Campagnolo D., Vollmer T.L., Bomprezzi R. Demyelinating disease and polyvalent human papilloma virus vaccination. J. Neurol. Neurosurg. Psychiatr. 2010, 9:1-3.
25. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 2002, 70:462-473.
26. Couette M., Boisse M.F., Maison P., Brugieres P., Cesaro P., Chevalier X., Gherardi R.K., Bachoud-Levi A.C., Authier F.J. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J. Inorg. Biochem. 2009, 103:1571-1578.
27. Crombie D.W., Blaisdell J.L., MacPherson G. The treatment of silicosis by aluminum powder. Can. Med. Assoc. J. 1944, 50:318-328.
28. Cullen K.M. Perivascular astrocytes within Alzheimer's disease plaques. Neuroreport 1997, 8:1961-1966.
29. Dabeka R., Fouquet A., Belisle S., Turcotte S. Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions. Food Addit. Contam. A Chem. Anal. Control Expo. Risk Assess. 2011, 28:744-753.
30. David J.P., Ghozali F., Fallet-Bianco C., Wattez A., Delaire S., Boniface B., Di Menza C., Delacourte A. Glial reaction in the hippocampal formation is highly concentrated with aging in human brain. Neurosci. Lett. 1997, 235:53-56.
31. Dubois F., Bégin R., Cantin A., Massé S., Martel M., Bilodeau G., Dufresne A., Perreault G., Sébastien P. Aluminum inhalation reduces silicosis in a sheep model. Am. Rev. Respir. Dis. 1988, 137:1172-1179.
32. Eidelberg D., Sotrel A., Joachim C., Selkoe D.I., Forman A., Pendlebury W.W., Perl D.P. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. Brain 1987, 110:993-1013.
33. Erasmus R.T., Kusnir J., Stevenson W.C., Lobo P., Herman M.M., Wills M.R., Savory J. Hyperaluminemia associated with liver transplantation and acute renal failure. Clin. Transplant. 1995, 9:307-311.
34. Evans P.H., Peterhans E., Burg T., Klinowski J. Aluminosilicate-induced free radical generation by murine brain glial cells in vitro: potential significance in the aetiopathogenesis of Alzheimer's dementia. Dementia 1992, 3:1-6.
35. Exley C. ATP-promoted amyloidosis of an amyloid β-peptide. Neuroreport 1997, 8:3411-3414.
36. Exley C., Esiri M.M. Severe cerebral congophilic angiopathy coincident with increased brain aluminum in a resident of Camelford, Cornwall, UK. J. Neurol. Neurosurg. Psychiatr. 2006, 77:877-879.
37. Exley C., Mamutse G., Korchazhkina O., Pye E., Strekopytov S., Polwart A., Hawkins C. Elevated urinary excretion of aluminum and iron in multiple sclerosis. Mult. Scler. 2006, 12:533-540.
38. Exley C., House E., Polwart A., Esiri M.M. Brain burdens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains. J. Alzheimer's Dis. 2012, 31:725-730.
39. Fimreite N., Hansen O.O., Pettersen H.C. Aluminum concentrations in selected foods prepared in aluminum cookware, and its implications for human health. Bull. Environ. Contam. Toxicol. 1997, 58:1-7.
40. Flaten T.P. Aluminum as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res. Bull. 2001, 55:187-196.
41. Galic M.A., Riazi K., Heida J.G., Mouihate A., Fournier N.M., Spencer S.J., Kalynchuk L.E., Teskey G.C., Pittman Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci. 2008, 28:6904-6913.
42. Garruto R.M., Shankar S.K., Yanagihara R., Salazar A.M., Amyx H.L., Gajdusek D.C. Low-calcium, high-aluminum diet-induced motor neuron pathology in cynomolgus monkeys. Acta Neuropathol. (Berlin) 1988, 78:210-219.
43. Giorgianni C.M., D'Arrigo G., Brecciaroli R., Abbate A., Spatari G., Tringali M.A., Gangemi S., De Luca A. Neurocognitive effects in welders exposed to aluminium. Toxicol. Ind. Health 2012, (Epub ahead of print) PMID: 22914260.
44. Girard M. Autoimmune hazards of hepatitis B vaccine. Autoimmun. Rev. 2005, 4:96-100.
45. Hald A., Van Beek J., Lotharius J. Inflammation in Parkinson's disease: causative or epiphenomenal?. Subcell. Biochem. 2007, 42:249-279.
46. Harris W.R., Wang Z., Hamada Y.Z. Competition between transferrin and the serum ligands citrate and phosphate for the binding of aluminum. Inorg. Chem. 2003, 42:3262-3273.
47. Kawahara M., Kato-Negishi M. Link between aluminum and the pathogenesis of Alzheimer's disease: the integration of the aluminum and amyloid cascade hypotheses. Int. J. Alzheimer's Dis. 2011, 10.4061/2011/276393.
48. Kennedy M.C.S. Aluminum powder inhalations in the treatment of silicosis of pottery workers and pneumoconiosis of coal-miners. Br. J. Ind. Med. 1956, 13:85-101.
49. Kiesswetter E., Schäper M., Buchta M., Schaller K.H., Rossbach B., Kraus T., Letzel S. Longitudinal study on potential neurotoxic effects of aluminium. II. Assessment of exposure and neurobehavioral performance of Al welders in the automobile industry over 4 years. Int. Arch. Occup. Environ. Health 2009, 82:1191-1210.
50. Kochian L.V., Jones D.L. Aluminum toxicity and resistance in plants. Research Issues in Aluminum Toxicity 1997, 69-90. Taylor and Francis, Washington. R.A. Yokel, M.S. Golub (Eds.).
51. Krewski D., Yokel R.A., Nieboer E., Borchelt D., Cohen J., Harry J., Kacew S., Lindsay J., Mahfouz A.M., Rondeau V. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B Crit. Rev. 2007, 10(Suppl. 1):1-269.
52. LaZerte B.D., Van Loon G., Anderson B. Aluminum in water. Research Issues in Aluminum Toxicity 1997, 17-46. Taylor and Francis, Washington, DC. R.A. Yokel, M.S. Golub (Eds.).
53. Li H., Campbell A., Ali S.F., Cong P., Bondy S.C. Chronic exposure to low levels of aluminum alters cerebral cell signaling in response to acute MPTP treatment. Toxicol. Ind. Health 2008, 23:515-524.
54. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
55. Lukiw W.J. Evidence supporting a biological role for aluminum in chromatin compaction and epigenetics. J. Inorg. Biochem. 2010, 104:1010-1012.
56. McLachlan D.R.C., Bergeron C., Smith J.E., Boomer D., Rifat S.L. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology 1996, 46:401-405.
57. McLachlan D.R.C., Dalton A.J., Kruck T.P.A., Bell M.Y., Smith W.L., Kalow W., Andrews D.F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 1991, 337:1304-1308.
58. Miu A.C., Olteanu A.I., Miclea M. A behavioral and ultrastructural dissection of the interference of aluminum with aging. J. Alzheimer's Dis. 2004, 6:315-328.
59. Mrak R.E., Sheng J.G., Griffin W.S.T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 1995, 26:816-823.
60. Nagatsu T., Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Des. 2005, 11:999-1016.
61. Napierska D., Rabolli V., Thomassen L.C., Dinsdale D., Princen C., Gonzalez L., Poels K.L., Kirsch-Volders M., Lison D., Martens J.A., Hoet P.H. Oxidative stress induced by pure and iron-doped amorphous silica nanoparticles in subtoxic conditions. Chem. Res. Toxicol. 2012, 25:828-837.
62. Needleman H.L. The case of Deborah Rice: who is the Environmental Protection Agency protecting?. PLoS Biol. 2008, 6:e129. 10.1371/journal.pbio.0060129.
63. Perl D.P., Brody A.R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 1980, 208:297-299.
64. Perl D.P., Gajdusek D.C., Garruto R.M., Yanagihara R.T., Gibbs C.J. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 1982, 217:1053-1055.
65. Petrik M.S., Wong M.C., Tabata R.C., Garry R.F., Shaw C.A. Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. Neuromol. Med. 2007, 9:83-100.
66. Phelps K.R., Naylor K., Brien T.P., Wilbur H., Haqqie S.S. Encephalopathy after bladder irrigation with alum: case report and literature review. Am. J. Med. Sci. 1999, 318:181-185.
67. Platt B., Fiddler G., Riedel G., Henderson Z. Aluminum toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res. Bull. 2001, 55:257-267.
68. Polizzi S., Pira E., Ferrara M., Bugiani M., Papaleo A., Albera R., Palmi S. Neurotoxic effects of aluminum among foundry workers and Alzheimer's disease. Neurotoxicology 2002, 23:761-774.
69. Pratico D., Uryu K., Sung S., Tang S., Trojanowski J.Q., Lee V.M. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 2002, 16:1138-1140.
70. Priest N.D., Talbot R.J., Newton D., Day J.P., King S.J., Fifield L.K. Uptake by man of aluminum in a public water supply. Hum. Exp. Toxicol. 1988, 17:296-301.
71. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
72. Qureshi M., Brown R.H., Rogers J.T., Cudkowicz M.E. Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis. Open Neurol. J. 2008, 2:51-54.
73. Reusche E., Seydel U. Dialysis associated encephalopathy: light and electron microscopic morphology and topograpy with evidence of aluminum by laser microprobe mass analysis. Acta Neuropathol. 1993, 86:249-258.
74. Ribes D., Colomina M.T., Vicens P., Domingo J.L. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp. Neurol. 2008, 214:293-300.
75. Rifat S.L., Eastwood M.R., McLachlan D.R., Corey P.N. Effect of exposure of miners to aluminum powder. Lancet 1990, 336:1162-1165.
76. Rondeau V., Jacqmin-Gadda H., Commenges D., Helmer C., Dartigues J.F. Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am. J. Epidemiol. 2009, 169:489-496.
77. Russo L.S., Beale G., Sandroni S., Ballinger W.E. Aluminum intoxication in undialysed adults with chronic renal failure. J. Neurol. Neurosurg. Psychiatr. 1992, 155:697-700.
78. Selley M.L. Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice. Brain Res. 2005, 1037:1-6.
79. Sharman E.H., Sharman K.Z., Bondy S.C. Melatonin causes gene expression in aged animals to respond to inflammatory stimuli in a manner differing from that of young animals. Curr. Aging Sci. 2008, 1:152-158.
80. Sharman E., Sharman K.G., Lahiri D.K., Bondy S.C. Age-related changes in murine CNS mRNA gene expression are modulated by dietary melatonin. J. Pineal Res. 2004, 36:165-170.
81. Shaw C.A., Petrik M.S. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J. Inorg. Biochem. 2009, 103:1555-1562.
82. Sherrard D.J., Walker J.V., Boykin J.L. Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease. Am. J. Kidney Dis. 1988, 12:126-130.
83. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
84. Shin R.W., Kruck T.P., Murayama H., Kitamoto T. A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease. Brain Res. 2003, 961:139-146.
85. Shirabe T., Irie K., Uchida M. Autopsy case of aluminum encephalopathy. Neuropathology 2002, 22:206-210.
86. Shoenfeld Y., Agmon-Levin N. 'ASIA' autoimmune/inflammatory syndrome induced by adjuvants. J. Autoimmun. 2011, 36:4-8.
87. Sigel H., Sigel A. Metal ions in biological systems. Aluminum and Its Role in Biology 1988, vol. 24. Marcel Dekker, New York.
88. Smith R.W. Kinetic aspects of aqueous aluminum chemistry: environmental implications. Coord. Chem. Rev. 1996, 149:81-93.
89. Sparling D.W., Campbell P.G.C. Ecotoxicology of aluminum to fish and wildlife. Research Issues in Aluminum Toxicity 1997, 48-68. Taylor and Francis, Washington, DC. R.A. Yokel, M.S. Golub (Eds.).
90. Styren S.D., Kamboh M.I., Dekosky S.T. Expression of differential immune factors in temporal cortex and cerebellum: the role of α-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease. J. Comp. Neurol. 1998, 396:511-520.
91. Sun Y.X., Minthon L., Wallmark A., Warkentin S., Blennow K., Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement. Geriat. Cognit. Disord. 2003, 16:136-144.
92. Sutton I., Lahoria R., Tan I.L., Clouston P., Barnett M.H. CNS demyelination and quadrivalent HPV vaccination. Mult. Scler. 2009, 15:116-119.
93. Tomljenovic L. Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link?. J. Alzheimer's Dis. 2011, 23:567-598.
94. Uversky V.N., Li J., Fink A.L. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 2001, 276:44284-44296.
95. Wållberg M., Wefer J., Harris R.A. Vaccination with myelin oligodendrocyte glycoprotein adsorbed to alum effectively protects DBA/1 mice from experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2003, 33:1539-1547.
96. Walton J.R. Brain lesions comprised of aluminum rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer's disease. Neurotoxicology 2009, 30:1059-1069.
97. Walton J.R. Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. Neurotoxicology 2009, 30:182-193.
98. Walton J.R., Wang M.X. APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. J. Inorg. Biochem. 2009, 103:1548-1554.
99. Walton J.R. Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment. Int. J. Alzheimer's Dis. 2012, 10.1155/2012/914947.
100. Xu N., Majidi V., Markesbery W.R., Ehmann W.D. Brain aluminum in Alzheimer's disease using an improved GFAAS method. Neurotoxicology 1992, 13:735-743.
101. Yokel R.A., O'Callaghan J.P. An aluminum-induced increase in GFAP is attenuated by some chelators. Neurotoxicol. Teratol. 1998, 20:55-60.
102. Yokel R.A., Rhineheimer S.S., Sharma P., Elmore D., McNamara P.J. Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure. Toxicol. Sci. 2001, 64:77-82.
103. Yumoto S., Kakimi S., Ohsaki A., Ishikawa A. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J. Inorg. Biochem. 2009, 103:1579-1584.
104. Zatta P., Zambenedetti P., Milanese M. Activation of monoamine oxidase type-B by aluminum in rat brain homogenate. Neuroreport 1999, 10:3645-3648.
105. Zhao M., Cribbs D.H., Anderson A.J., Cummings B.J., Su J.H., Wasserman A.J., Cotman C.W. The induction of the TNF alpha death domain signaling pathway in Alzheimer's disease brain. Neurochem. Res. 2003, 28:307-318.